Sign in
CompletedNo phase

Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty

Key facts

Who runs it
Chiayi Christian Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
150 people enrolled
Started
1 Feb 2023
Ended
21 Sept 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Rivaroxaban 10 MG
Record updated
24 April 2026

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Undergo total knee replacement or total hip replacement

Who cannot take part

  • A history of a coagulopathy
  • Recent thromboembolic disease
  • Preoperative deep vein thrombosis screening presents positive
  • Age below 20
  • Recent antithrombotics use

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Venous thromboembolism is a serious complication after total hip replacement (THR) and total knee replacement (TKR). Previous studies have reported the incidence of both asymptomatic and symptomatic deep vein thrombosis (DVT) after TKR were higher in Taiwan than other countries in Asia. Therefore, the usage of prophylactic antithrombotics should be considered. The efficacy and safety of Xarelto (Rivaroxaban) for preventing venous thromboembolism has been proved. However, there is a lack of study using prospective design to evaluate the efficacy and safety of Xarelto after THR and TKR for Taiwanese. In this study, the investigators use a randomized controlled trial design comparing the incidence of DVT, pulmonary embolism, and complications between intervention and control groups.

The 2 groups in the trial

  • RivaroxabanTreatment being tested

    The participants are provided with Rivaroxaban 10mg

    Treatment: Rivaroxaban 10 MG

  • ControlNo study treatment, for comparison

    The participants are provided without antithrombotics

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
24 April 2026